Cannabis Central: These 16 Pot Stocks Are Listed On The Australian Stock Exchange
TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.
It has been predicted by Prohibition Partners that the Oceania region will be worth $1.55B by 2024, with 79% of that being comprised within Australia so Australia's The Green Fund, a global research house with a focus on the cannabis industry has created the Australian Cannabis Index.
The equal weighted index is denominated in Australian dollars (go here to convert prices into other currencies) and includes all 16 publicly-traded companies in Australia allowing investors to compare current price levels with past prices to calculate market performance and the health of the Australian cannabis industry.
Only one of the index constituents trades for more than A$1/share and that company, Ecofibre Ltd., has a market cap over A$800M. 5 other companies have market caps between A$50M and A$100M with the remaining 10 companies with market caps of less than A$50M. Below is a full list of the index constituents:
- Ecofibre (OTCPK: EOFBF: ASX:EOF)
- Cann Group (OTCPK:CNGGF; ASX:CAN)
- AusCann Group (OTCPK: ACNNF; ASX:ACB)
- Elixinol Global (OTCPK: ELLXF; ASX:EXL)
- MGC Pharmaceutical (OTCPK: MGCLF; ASX:MXC)
- Althea Group (ASX:AGH)
- Zelda Therapeutics (ASX:ZLD)
- Botanix Pharmacueticals (ASX:BOT)
- Impression Healthcare (ASX:IHL)
- Little Green Pharma (ASX:LGP)
- The Hydroponics Company (ASX:THC)
- IDT Australia (ASX:IDT)
- MedLab Clinical (ASX:MDC)
- Bod Australia (ASX:BDA)
- EVE Investments (ASX:EVE)
- Creso Pharma (ASX:CPH)
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more